OKYO Pharma Limited Announces Withdrawal of Public Offering
July 31, 2023 02:18 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...
OKYO Pharma Announces Proposed Public Offering of Ordinary Shares
July 28, 2023 17:25 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
July 25, 2023 08:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...
Prelude Therapeutics Announces Pricing of Public Offering
May 18, 2023 07:00 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., May 18, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated ("Prelude" or the "Company") (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the...
GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock
April 17, 2023 09:15 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock
April 13, 2023 09:22 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 13, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock
April 12, 2023 17:50 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 12, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
Draganfly Closes US$8.0 Million Underwritten Public Offering to Secure Growth Capital
March 31, 2023 10:10 ET
|
Draganfly Inc
Los Angeles, CA., March 31, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a drone solutions and systems developer, announced the...
Draganfly Announces Pricing of US$8.0 Million Underwritten Public Offering to Secure Growth Capital
March 29, 2023 08:55 ET
|
Draganfly Inc
Los Angeles, CA., March 29, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a drone solutions and systems developer, today announced the...
Draganfly Announces Proposed Underwritten Public Offering to Secure Growth Capital
March 28, 2023 20:01 ET
|
Draganfly Inc
Los Angeles, CA., March 28, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a drone solutions and systems developer, today announced...